Funding, launches and regulatory moves across the neurotech startup map.
Subscribed. Check your inbox to confirm.
Yneuro
news and updates
16 Oct 2026: Founder Thomas Semah told Neurofounders that Yneuro is signing its first contracts in government, defence, finance and critical infrastructure. Its Neuro ID software was trained on EEG recordings from more than 108,000 people across 125 recording configurations, and the company holds six international patent families. Read our interview.
Jan 2026: Yneuro announced Neuro ID at CES 2026. It identifies users by their brain activity, through EEG sensors in earbuds and smart glasses. The Paris company, backed by angel investors and Bpifrance, plans to raise in 2026 to expand into the US, South Korea and Japan.
•
Neurofounders Insights
$ Funding -
Seed
MODALITY
Software
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Other
TARGET USER
Developers
REGULATORY STAGE
Non-medical
Yneuro sits in the niche category of neural biometrics, using brain-derived signatures as a form of authentication. It is an interesting application-layer business, though likely narrower in commercial scope than core neurodiagnostics or interface platforms.